
Expression of CD10 in urothelial carcinoma of the bladder and its correlation with histopathological grade, pathological stage, and survival of patients
Author(s) -
Sushil Kumar Shukla,
Smita Chandra,
Neena Chauhan,
Rajeev Sarpal
Publication year - 2021
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/jcrt.jcrt_619_18
Subject(s) - immunostaining , pathological , stage (stratigraphy) , urothelium , medicine , pathology , carcinoma , histopathology , pathogenesis , immunohistochemistry , urothelial carcinoma , oncology , bladder cancer , urinary bladder , cancer , biology , paleontology
CD10 plays a role in signal transduction pathway and regulation of cell growth apoptosis, and therefore, it has been evaluated in different malignancies. The present study was conducted to study the immunoexpression of CD10 in urothelial carcinoma and to correlate it with histological grade, pathological stage, and survival of patients.